10-Q/A 1 v233185_10qa.htm FORM 10-Q/A Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

x
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
   
 
For the quarterly period ended June 30, 2011

or
 
 o
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
   
 
For the transition period from ______ to ______.
  
Commission File Number 001-34394
 
 
SKYSTAR BIO-PHARMACEUTICAL COMPANY
(Exact name of small business issuer as specified in its charter)

Nevada
33-0901534
(State or other jurisdiction of
(I.R.S. employer
incorporation or organization)
identification number)

4/F Building B, Chuangye Square, No. 48 Keji Road,
Gaoxin District, Xi’an Province, P.R. China
(Address of principal executive offices and zip code)

(8629) 8819-3188
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x      No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x    No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):
 
 
Large Accelerated Filer o
Accelerated Filer o
 
Non-accelerated filer o
Smaller Reporting Company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).      Yes  o    No x

APPLICABLE ONLY TO CORPORATE ISSUERS:

As of August 15, 2011, the Registrant had 7,161,919 shares of common stock outstanding.
 
 
 
 
 
Explanatory Note
 
The purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission on August 22, 2011, is to furnish the interactive data files in accordance with Rule 405 of Regulation S–T.
 
This Form 10-Q/A should be read in conjunction with the original Form 10-Q, which continues to speak as of the date of the Form 10-Q. Except as specifically noted above, this Form 10-Q/A does not modify or update disclosures in the original Form 10-Q. Accordingly, this Form 10-Q/A does not reflect events occurring after the filing of the Form 10-Q or modify or update any related or other disclosures.
 
Item 6.  Exhibits.

ITEM 6. EXHIBITS
 
Exh. No.
  
Description
3.1
  
Articles of Incorporation, as amended  (2)
     
3.2
  
Bylaws, as amended (1)
     
31.1
  
Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (3)
     
31.2
  
Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (3)
     
32.1
  
Certifications of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (3)
     
32.2
  
Certifications of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (3)
 
101.INS*
  
XBRL Instance Document
     
101.SCH*
  
XBRL Taxonomy Extension Schema
     
101.CAL*
  
XBRL Taxonomy Extension Calculation Linkbase
     
101.DEF*
  
XBRL Taxonomy Extension Definition Linkbase
     
101.LAB*
  
XBRL Taxonomy Extension Label Linkbase
     
101.PRE*
  
XBRL Taxonomy Extension Presentation Linkbase

*
In accordance with Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q/A shall be deemed “furnished” and not “filed.”
   
(1)
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed on July 15, 2008.
   
(2)
Incorporated by reference from Registrant’s Quarter Report on Form 10-Q filed on November 15, 2010.
 
 (3)
Incorporated by reference from Registrant’s Quarter Report on Form 10-Q filed on August 22, 2011.
 
 
 
2
 
 
SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
SKYSTAR BIO-PHARMACEUTICAL COMPANY
  
       
September 21, 2011
By:  
/s/ Weibing Lu
  
   
Weibing Lu
  
   
Chief Executive Officer
  
   
(Principal Executive Officer)
  
 
       
September 21, 2011
By:  
/s/ Bing Mei
  
   
Bing Mei
  
   
Chief Financial Officer
  
   
(Principal Financial and Accounting Officer)
  
 
 

 
3